BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models. World J Gastroenterol 2018; 24(17): 1888-1900 [PMID: 29740204 DOI: 10.3748/wjg.v24.i17.1888]
URL: https://www.wjgnet.com/2150-5349/full/v24/i17/1888.htm
Number Citing Articles
1
Charles F. Barish, Robert A. Crozier, Patrick H. Griffin. Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipationCurrent Medical Research and Opinion 2019; 35(1): 81 doi: 10.1080/03007995.2018.1527303
2
Dong-ha Kim, Ji-Su Kim, Jae-Hee Kwon, In-Sook Kwun, Moon-Chang Baek, Gi-Seok Kwon, Wiramon Rungratanawanich, Byoung-Joon Song, Do-Kyun Kim, Hyo-Jung Kwon, Young-Eun Cho. Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome ChangesAntioxidants 2023; 12(10): 1886 doi: 10.3390/antiox12101886
3
Ariana A. Entezari, Adam E. Snook, Scott A. Waldman. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potentialExpert Opinion on Therapeutic Targets 2021; 25(5): 335 doi: 10.1080/14728222.2021.1937124
4
Walter Cabri, Paolo Cantelmi, Dario Corbisiero, Tommaso Fantoni, Lucia Ferrazzano, Giulia Martelli, Alexia Mattellone, Alessandra Tolomelli. Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and PerspectivesFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.697586
5
V. Andresen, G. Becker, T. Frieling, M. Goebel-Stengel, F. Gundling, A. Herold, M. Karaus, J. Keller, M. Kim, P. Klose, H. Krammer, M. E. Kreis, R. Kuhlbusch-Zicklam, J. Langhorst, P. Layer, R. Lenzen-Großimlinghaus, A. Madisch, H. Mönnikes, S. Müller-Lissner, D. Rubin, M. Schemann, J. Schwille-Kiuntke, A. Stengel, M. Storr, I. van der Voort, W. Voderholzer, T. Wedel, S. Wirz, H. Witzigmann, C. Pehl. Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019Zeitschrift für Gastroenterologie 2022; 60(10): 1528 doi: 10.1055/a-1880-1928
6
Jeffrey A. Rappaport, Scott A. Waldman. The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and NeoplasiaFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00299
7
David O. Prichard, Adil E. Bharucha. Recent advances in understanding and managing chronic constipationF1000Research 2018; 7: 1640 doi: 10.12688/f1000research.15900.1
8
Joshua R. Barton, Annie K. Londregan, Tyler D. Alexander, Ariana A. Entezari, Manuel Covarrubias, Scott A. Waldman. Enteroendocrine cell regulation of the gut-brain axisFrontiers in Neuroscience 2023; 17 doi: 10.3389/fnins.2023.1272955
9
David S. Weinberg, Nathan R. Foster, Gary Della’Zanna, Ryan P. McMurray, Walter K. Kraft, Angela Pallotto, David M. Kastenberg, Leo C. Katz, Christopher H. Henry, Stephanie M. Moleski, Paul J. Limburg, Scott A. Waldman. Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteersCancer Biology & Therapy 2021; 22(10-12): 544 doi: 10.1080/15384047.2021.1967036
10
Stuart M. Brierley, Luke Grundy, Joel Castro, Andrea M. Harrington, Gerhard Hannig, Michael Camilleri. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral painTrends in Pharmacological Sciences 2022; 43(2): 110 doi: 10.1016/j.tips.2021.11.002
11
Sarah Adriana Scuderi, Giovanna Casili, Marika Lanza, Alessio Ardizzone, Luca Pantaleo, Michela Campolo, Irene Paterniti, Laura Cucinotta, Salvatore Cuzzocrea, Emanuela Esposito. Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal ModelInternational Journal of Molecular Sciences 2022; 23(4): 2269 doi: 10.3390/ijms23042269
12
Liangen Yu, Yihang Li. Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric DisordersBiomedicines 2022; 10(10): 2577 doi: 10.3390/biomedicines10102577
13
Alison Accarie, Tim Vanuytsel. Animal Models for Functional Gastrointestinal DisordersFrontiers in Psychiatry 2020; 11 doi: 10.3389/fpsyt.2020.509681
14
Lu-lu Ren, Jia-yi Zhou, Shao-jie Liang, Xiu-qi Wang. Impaired intestinal stem cell activity in ETEC infection: enterotoxins, cyclic nucleotides, and Wnt signalingArchives of Toxicology 2022; 96(5): 1213 doi: 10.1007/s00204-021-03213-x
15
Chengfeng Xing, Tao Zhang, Xiaolin Liu, Canmei Li, Gang Yang, Hairong Zhang, Rui Wang, Kunhua Wang, Yinglei Miao, Danfeng Lan. Guanylin ligand protects the intestinal immune barrier by activating the guanylate cyclase-C signaling pathwayActa Histochemica 2022; 124(1): 151811 doi: 10.1016/j.acthis.2021.151811
16
Thomas Kremsmayr, Aws Aljnabi, Juan B. Blanco-Canosa, Hue N. T. Tran, Nayara Braga Emidio, Markus Muttenthaler. On the Utility of Chemical Strategies to Improve Peptide Gut StabilityJournal of Medicinal Chemistry 2022; 65(8): 6191 doi: 10.1021/acs.jmedchem.2c00094
17
Lin Chang, Shahnaz Sultan, Anthony Lembo, G. Nicholas Verne, Walter Smalley, Joel J. Heidelbaugh. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With ConstipationGastroenterology 2022; 163(1): 118 doi: 10.1053/j.gastro.2022.04.016
18
Joshua R. Barton, Annie K. Londregran, Tyler D. Alexander, Ariana A. Entezari, Shely Bar-Ad, Lan Cheng, Angelo C. Lepore, Adam E. Snook, Manuel Covarrubias, Scott A. Waldman. Intestinal neuropod cell GUCY2C regulates visceral painJournal of Clinical Investigation 2023; 133(4) doi: 10.1172/JCI165578
19
Laura López-Gómez, Ana Bagüés, José Antonio Uranga, Raquel Abalo. A Comprehensive Overview of Irritable Bowel Syndrome2020; : 233 doi: 10.1016/B978-0-12-821324-7.00012-5